Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 119 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1181 10.0 months Advanced NSCLC 5 Chemotherapy
S.G. Moscati Hospital Italy 10/2007
Treatment Details: Patients: The phase II portion of this study involved 121 patients with advanced non-small-cell lung cancer. The median age was 73, ranging from 67 to 83 years old. The majority of patien
 
1182 10.0 months Metastatic renal cell carcinoma 5 Biologic therapy
Institut Gustave Roussy France 7/2002
Treatment Details: Patients: This Phase II trial involved 40 patients with metastatic renal cell carcinoma; 32 men and 8 women. Previous treatments had included nephrectomy (32 patients), radiotherapy (15 pat
 
1183 10.0 months Metastatic renal cell cancer 4 Biologic therapy
Barbara Ann Karmanos Cancer Institute United States 11/2003
Treatment Details: Patients: This Phase II study involved 24 patients with metastatic renal cell cancer; 16 men and 8 women. The median age was 60.5 years. Seventeen patients had undergone a prior nephrectom
 
1184 10.0 months Metastatic renal cell carcinoma 4 Chemotherapy
University of Chicago United States 1/2002
Treatment Details: Patients: This Phase II study involved 21 patients with metastatic renal cell carcinoma; 13 men and 8 women. The median age was 58 years. Twelve patients had undergone a prior nephrectomy
 
1185 10.0 months Advanced renal cell carcinoma 4 Biologic therapy
University of Cincinnati Medical Center United States 7/2001
Treatment Details: Patients: This Phase II study involved 22 patients with advanced renal cell carcinoma; 19 men and 3 women. Treatment: The treatment consisted of the antiparasitic drug, suramin. Tox
 
1186 10.0 months Advanced renal cell carcinoma 3 Chemotherapy
Hormone
Taipei Veterans General Hospital and National Yang-Ming University China 7/2001
Treatment Details: Patients: This Phase II study involved 17 patients with advanced renal cell carcinoma; 16 men and 1 woman. Median age was 72 years. Treatment: The treatment consisted of tamoxifen (a dru
 
1187 10.0 months Malignant pleural mesothelioma 4 Radiation
Surgery
Memorial Sloan-Kettering Cancer Center United States 10/2001
Treatment Details: Patients: This Phase II study involved 88 patients with malignant pleural mesothelioma; 53 men and 15 women. The median age was 62.5 years. Treatment: The treatment consisted of surgery
 
1188 10.0 months hepatocellular carcinoma (inoperable) Biologic therapy
Radiation
Zhongshan Hospital, Fudan University China 10/2004
Treatment Details: Patients: This Phase I study involved a total of 37 patients with unresectable (inoperable) hepatocellular carcinoma. There were 28 men and 9 women and the average was 52.5 years. Treatm
 
1189 10.0 months Advanced rcc 3 Biologic therapy
Karmanos Cancer Institute United States 3/2005
Treatment Details: Patients: This Phase II study involved 19 patients with advanced renal carcinoma. 12 were men and 7 were women. The median age was 58. 17 patients had nephrectomies. Treatment: The tre
 
1190 10.0 months Advanced NSCLC 3 Chemotherapy
Sotiria General Hospital Greece 9/2005
Treatment Details: Patients: This Phase II study involved 31 patients with advanced NSCLC. Twenty-eight of the patients were men, and three were women. The median age was 66 years. Treatment: The treatmen
 
Page 119 of 187  | Previous Page  | Next Page